Magloire Pandoua Nekoua1, Rufine Fachinan1, Amidou K Atchamou1, Odilon Nouatin2, Daniel Amoussou-Guenou3, Marcellin K Amoussou-Guenou4, Kabirou Moutairou1, Akadiri Yessoufou1. 1. Laboratory of Cell Biology and Physiology, Institute of Applied Biomedical Sciences (ISBA) and Faculty of Sciences and Techniques, University of Abomey-Calavi, 01 BP 526 Cotonou, Bénin. 2. Centre d'Etude et de Recherche sur le Paludisme associé à la Grossesse et à l'Enfance IRD/UMR-216, Cotonou, Bénin. 3. Service of Internal Medicine, Centre National Hospitalier et Universitaire (CNHU) and Faculty of Health Sciences (FSS);, Cotonou, Bénin. 4. Service of Radio-immuno-assay (SERID), Faculty of Health Sciences (FSS); Cotonou, Bénin.
Abstract
BACKGROUND: The role of the immune system in insulin resistance associated with type 2 diabetes has been suggested. OBJECTIVES: We assessed the profile of Th1/Th2 cytokines along with the frequencies of immune cells in insulin-treated type 2 diabetic patients (T2DP). METHODS: 45 T2D patients and 43 age-matched healthy subjects were selected. Serum concentrations of T-helper type 1 (Th1) and Th2 cytokines and the frequencies of innate and adaptive immunity cells were assessed. RESULTS: T2DP were hyperglycemic and showed high level of insulin, normal levels of triglycerides and total-cholesterol and without any change in HDL-cholesterol.Compared to healthy subjects, T2DP exhibited significant decreased frequencies of neutrophils, without any change in monocytes, eosinophils and natural killer cells. The percentages of total lymphocytes (CD3+) and CD8+-T-cells decreased whereas those of regulatory T-cells increased without any change in CD4+ T-cells in T2DP. Interestingly, the frequencies of effector CD4+-T and B-cells increased in T2DP. Serum concentrations of IL-2, IFN-γ and IL-4 decreased while IL-10 significantly enhanced in T2DP, suggesting a differentiation of CD4+T helper cells towards IL-10-producing-Teff-cells in these patients. CONCLUSION: Insulin-treated type 2 diabetes is associated with anti-inflammatory profile consistent with differentiation of CD4+-Th-cells towards IL-10-producing-Teff-cells, concomitant with increased frequencies of Treg and B-cells, and this may probably offer prevention against certain infections or autoimmune/inflammatory diseases.
BACKGROUND: The role of the immune system in insulin resistance associated with type 2 diabetes has been suggested. OBJECTIVES: We assessed the profile of Th1/Th2 cytokines along with the frequencies of immune cells in insulin-treated type 2 diabeticpatients (T2DP). METHODS: 45 T2D patients and 43 age-matched healthy subjects were selected. Serum concentrations of T-helper type 1 (Th1) and Th2 cytokines and the frequencies of innate and adaptive immunity cells were assessed. RESULTS: T2DP were hyperglycemic and showed high level of insulin, normal levels of triglycerides and total-cholesterol and without any change in HDL-cholesterol.Compared to healthy subjects, T2DP exhibited significant decreased frequencies of neutrophils, without any change in monocytes, eosinophils and natural killer cells. The percentages of total lymphocytes (CD3+) and CD8+-T-cells decreased whereas those of regulatory T-cells increased without any change in CD4+ T-cells in T2DP. Interestingly, the frequencies of effector CD4+-T and B-cells increased in T2DP. Serum concentrations of IL-2, IFN-γ and IL-4 decreased while IL-10 significantly enhanced in T2DP, suggesting a differentiation of CD4+T helper cells towards IL-10-producing-Teff-cells in these patients. CONCLUSION:Insulin-treated type 2 diabetes is associated with anti-inflammatory profile consistent with differentiation of CD4+-Th-cells towards IL-10-producing-Teff-cells, concomitant with increased frequencies of Treg and B-cells, and this may probably offer prevention against certain infections or autoimmune/inflammatory diseases.
Entities:
Keywords:
Immune cells; Insulin; Th1/Th2 polarization; Type 2 diabetes
Authors: S Müller; S Martin; W Koenig; P Hanifi-Moghaddam; W Rathmann; B Haastert; G Giani; T Illig; B Thorand; H Kolb Journal: Diabetologia Date: 2002-05-08 Impact factor: 10.122
Authors: Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-04-03 Impact factor: 8.082
Authors: Alina C R Feitosa; Gilson S Feitosa-Filho; Fatima R Freitas; Bernardo L Wajchenberg; Raul C Maranhão Journal: Lipids Health Dis Date: 2013-02-11 Impact factor: 3.876
Authors: A Seck; A Hichami; S Doucouré; F Diallo Agne; H Bassène; A Ba; C Sokhna; N A Khan; A Samb Journal: J Diabetes Res Date: 2018-11-14 Impact factor: 4.011
Authors: Nafiul Huda; Md Ismail Hosen; Tahirah Yasmin; Pankaj Kumar Sarkar; A K M Mahbub Hasan; A H M Nurun Nabi Journal: PLoS One Date: 2018-07-25 Impact factor: 3.240